Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAL American Airlines Group	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.39 +0.9%	$15.00	Neutral
AAP Advance Auto Parts	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Basham Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.68 -8.5%	$55.00 ➝ $55.00	Outperform ➝ Outperform
AAP Advance Auto Parts	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.68 -8.5%	$45.00 ➝ $45.00	Neutral ➝ Neutral
AAP Advance Auto Parts	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.68 -8.5%	$60.00 ➝ $43.00	Neutral ➝ Neutral
AAP Advance Auto Parts	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.68 -8.5%	$41.00 ➝ $39.00	Hold ➝ Hold
AAP Advance Auto Parts	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.68 -8.5%	$42.00 ➝ $44.00	Neutral ➝ Neutral
Watch this before it gets removed (Ad) If you missed it, my emergency election broadcast is now available - but will be removed soon Click here to watch it now.
ABBV AbbVie	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$164.91 -2.8%	$205.00	Outperform
ACGL Arch Capital Group	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$101.83 +1.8%	$143.00 ➝ $136.00	Buy ➝ Buy
ACIU AC Immune	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.19 -10.1%	$16.00 ➝ $16.00	Buy ➝ Buy
ACO.X ATCO	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$48.55 +0.4%	C$45.00 ➝ C$49.00
ACO.X ATCO	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$48.55 +0.4%	C$50.00 ➝ C$51.00
ACO.X ATCO	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$48.55 +0.4%	C$59.00 ➝ C$58.00
ACQ AutoCanada	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$18.90	C$15.50 ➝ C$15.00
ADAP Adaptimmune Therapeutics	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.59	$4.00 ➝ $3.00	Buy ➝ Buy
ADEN ADENTRA	Target Lowered by	Acumen Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.77 -4.2%	C$56.00 ➝ C$54.00
ADSK Autodesk	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$299.15 -2.4%	$310.00 ➝ $355.00	Overweight ➝ Overweight
ADSK Autodesk	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$299.15 -2.4%	$320.00 ➝ $340.00	Buy ➝ Buy
AFG American Financial Group	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$137.82 -0.1%	$135.00 ➝ $143.00	Market Perform ➝ Market Perform
AFMD Affimed	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.48 -4.7%	$5.00 ➝ $4.00	Hold ➝ Hold
AFMD Affimed	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.48 -4.7%	$10.00 ➝ $10.00	Buy ➝ Buy
AGYS Agilysys	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$121.19 +0.3%	$125.00 ➝ $145.00	Buy ➝ Buy
AHCO AdaptHealth	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.64 -4.0%	$13.00 ➝ $12.00	Buy ➝ Buy
AHR American Healthcare REIT	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$27.18 +3.7%	$27.00 ➝ $29.00	Buy ➝ Buy
AIN Albany International	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.09 -0.5%	$90.00 ➝ $80.00	Underperform ➝ Underperform
AKYA Akoya Biosciences	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.41 -23.0%	$6.00 ➝ $3.50	Buy ➝ Buy
AKYA Akoya Biosciences	Downgraded by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Bonello Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.41 -23.0%	$7.00 ➝ $5.00	Buy ➝ Hold
ALGT Allegiant Travel	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$77.69 +2.1%	$83.00	Neutral
ALK Alaska Air Group	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$53.96 +2.0%	$70.00	Buy
ALL Allstate	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$196.88 +0.6%	$209.00 ➝ $230.00	Buy ➝ Buy
ALLY Ally Financial	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$36.22	$50.00 ➝ $55.00	Buy ➝ Buy
ALYA Alithya Group	Target Lowered by	Ventum Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$1.68 -4.5%	C$2.70 ➝ C$2.50
ALYA Alithya Group	Target Lowered by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$1.68 -4.5%	C$2.50 ➝ C$2.00
AMAT Applied Materials	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$168.88 -9.2%	$220.00 ➝ $200.00	Hold ➝ Hold
AMAT Applied Materials	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$168.88 -9.2%	$185.00 ➝ $179.00	Equal Weight ➝ Equal Weight
AMAT Applied Materials	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$168.88 -9.2%	$240.00 ➝ $225.00	Buy ➝ Buy
AMAT Applied Materials	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$168.88 -9.2%	$250.00 ➝ $230.00	Buy ➝ Buy
AMAT Applied Materials	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$168.88 -9.2%	$235.00 ➝ $220.00	Overweight ➝ Overweight
AMAT Applied Materials	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$168.88 -9.2%	$260.00 ➝ $250.00	Outperform ➝ Outperform
AMAT Applied Materials	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$168.88 -9.2%	$220.00 ➝ $210.00	Buy ➝ Buy
AMAT Applied Materials	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$168.88 -9.2%	$250.00 ➝ $250.00	Overweight ➝ Overweight
Top "Sleeping Giant" Crypto In The Market Now (Ad) Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future. Click here to discover our #1 crypto pick before it's too late
AMGN Amgen	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$283.61 -4.2%		Peer Perform
AMTX Aemetis	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.83 -5.9%	$28.00 ➝ $28.00	Buy ➝ Buy
AMX América Móvil	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.10 +0.6%	$20.80 ➝ $17.80	Buy ➝ Buy
ANNX Annexon	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.12 -3.3%	$30.00 ➝ $30.00	Buy ➝ Buy
ANNX Annexon	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.12 -3.3%	$16.00 ➝ $16.00	Buy ➝ Buy
ANNX Annexon	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.12 -3.3%		Overweight
APPS Digital Turbine	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.31 -6.4%	$3.50 ➝ $1.00	Neutral ➝ Underperform
APR.UN Automotive Properties Real Est Invt TR	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$12.15 -1.4%	C$12.00 ➝ C$13.00	Hold
APR.UN Automotive Properties Real Est Invt TR	Target Raised by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$12.15 -1.4%	C$12.75 ➝ C$13.00
ARE Alexandria Real Estate Equities	Target Lowered by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.55 -2.5%	$140.00 ➝ $130.00	Market Outperform ➝ Market Outperform
ARE Alexandria Real Estate Equities	Downgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.55 -2.5%	$135.00 ➝ $112.00	Buy ➝ Hold
ARI Apollo Commercial Real Estate Finance	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.08 -0.4%	$10.00 ➝ $9.50	Neutral ➝ Neutral
ASND Ascendis Pharma A/S	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Y. Zhong Subscribe to MarketBeat All Access for the recommendation accuracy rating	$126.51 +1.8%	$181.00 ➝ $181.00	Outperform ➝ Outperform
ASND Ascendis Pharma A/S	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$126.51 +1.8%	$170.00 ➝ $170.00	Overweight ➝ Overweight
ASND Ascendis Pharma A/S	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$126.51 +1.8%	$190.00 ➝ $180.00	Outperform ➝ Outperform
ASND Ascendis Pharma A/S	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$126.51 +1.8%	$200.00 ➝ $207.00	Buy ➝ Buy
ASND Ascendis Pharma A/S	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Y. Werber Subscribe to MarketBeat All Access for the recommendation accuracy rating	$126.51 +1.8%	$160.00 ➝ $153.00	Buy ➝ Buy
ASTS AST SpaceMobile	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.23 -9.6%	$45.90 ➝ $44.70	Sector Outperform ➝ Sector Outperform
ASTS AST SpaceMobile	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.23 -9.6%	$30.00 ➝ $31.00	Buy ➝ Buy
ATNM Actinium Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.50 -9.1%	$4.00 ➝ $4.00	Buy ➝ Buy
AUTL Autolus Therapeutics	Upgraded by	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.08 +2.3%	$13.00	Neutral ➝ Buy
AVBP ArriVent BioPharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$27.21 -3.1%	$36.00 ➝ $36.00	Buy ➝ Buy
AYA Aya Gold & Silver	Downgraded by	Cormark Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$12.72 +7.8%	C$20.00 ➝ C$14.00	Speculative Buy ➝ Market Perform
BABA Alibaba Group	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$88.57 -2.2%	$118.00 ➝ $118.00	Buy ➝ Buy
BAC Bank of America	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.75 +1.9%	$52.00 ➝ $56.00	Overweight ➝ Overweight
BASE Couchbase	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Lenschow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$19.25 +0.4%	$19.00 ➝ $23.00	Overweight ➝ Overweight
BBIO BridgeBio Pharma	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Harrison Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.72 -1.6%	$44.00 ➝ $45.00	Sector Outperform ➝ Sector Outperform
BE Bloom Energy	Upgraded by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.15 +59.2%	$10.00 ➝ $20.00	Neutral ➝ Overweight
BE Bloom Energy	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.15 +59.2%	$12.00 ➝ $19.50	Market Perform ➝ Market Perform
BE Bloom Energy	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.15 +59.2%	$16.00 ➝ $20.00	Buy ➝ Buy
BIIB Biogen	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$159.99 -3.0%		Peer Perform
BIIB Biogen	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$159.99 -3.0%	$294.00 ➝ $300.00	Outperform ➝ Outperform
BILI Bilibili	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.30 -1.6%	$16.00 ➝ $24.00	Buy ➝ Buy
BIR Birchcliff Energy	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$4.94 -3.7%	C$6.00 ➝ C$5.75
BJ BJ's Wholesale Club	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$87.23 +0.3%	$95.00 ➝ $105.00	Buy ➝ Buy
BK Bank of New York Mellon	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$78.29 +0.9%	$79.00 ➝ $81.00	Equal Weight ➝ Equal Weight
BL BlackLine	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.31 -2.1%	$70.00 ➝ $80.00	Overweight ➝ Overweight
BLTE Belite Bio	Target Raised by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$82.81 -1.0%	$60.00 ➝ $110.00	Buy ➝ Buy
BLUE bluebird bio	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.32 -11.1%	$4.00 ➝ $4.00	Sector Perform ➝ Sector Perform
BLUE bluebird bio	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.32 -11.1%	$3.00 ➝ $0.50	Buy ➝ Neutral
BLUE bluebird bio	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.32 -11.1%		Neutral ➝ Underweight
BLUE bluebird bio	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.32 -11.1%	$4.00 ➝ $2.00	Overweight ➝ Overweight
BLX Boralex	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$31.80 -3.3%	C$43.00 ➝ C$42.00
BLX Boralex	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$31.80 -3.3%	C$46.00 ➝ C$45.00
BMO Bank of Montreal	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Mendonca Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$131.32 +0.0%	C$114.00 ➝ C$131.00
BMRN BioMarin Pharmaceutical	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.42 -3.3%	$95.00	Outperform
BMY Bristol-Myers Squibb	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.22 -3.9%		Peer Perform
BN Brookfield	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.79 -1.7%	$50.00 ➝ $62.00	Outperform ➝ Outperform
BN Brookfield	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.79 -1.7%	$65.00 ➝ $69.00	Sector Outperform ➝ Sector Outperform
BNGO Bionano Genomics	Downgraded by	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.25 -3.9%		Buy ➝ Neutral
I was wrong. Dead wrong. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.
BNS Bank of Nova Scotia	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Mendonca Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$75.94 +0.3%	C$80.00 ➝ C$82.00
BPMC Blueprint Medicines	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$88.69 -7.3%	$135.00 ➝ $135.00	Buy ➝ Buy
BPMC Blueprint Medicines	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$88.69 -7.3%	$135.00 ➝ $135.00	Buy ➝ Buy
BRX Brixmor Property Group	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.83 +0.5%	$28.00 ➝ $31.00	Buy ➝ Buy
BV BrightView	Upgraded by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.66 -1.0%		Market Perform ➝ Outperform
BV BrightView	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.66 -1.0%	$11.30 ➝ $12.90	Sell ➝ Sell
BV BrightView	Target Raised by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Stevenson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.66 -1.0%	$18.00 ➝ $20.00	Buy ➝ Buy
BXSL Blackstone Secured Lending Fund	Target Lowered by	Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating		$30.87 -0.2%	$33.50 ➝ $32.25	Buy ➝ Buy
C Citigroup	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$68.76 +0.9%	$85.00 ➝ $95.00	Overweight ➝ Overweight
CABA Cabaletta Bio	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.03 -19.8%	$25.00 ➝ $25.00	Buy ➝ Buy
CABA Cabaletta Bio	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.03 -19.8%	$20.00 ➝ $12.00	Overweight ➝ Overweight
CAVA CAVA Group	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Mullan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$141.23 +2.1%	$100.00 ➝ $142.00	Neutral ➝ Neutral
CBRL Cracker Barrel Old Country Store	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.81 +1.5%	$42.00 ➝ $45.00	Underperform ➝ Underperform
CBRL Cracker Barrel Old Country Store	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.81 +1.5%	$44.00 ➝ $48.00	Hold ➝ Hold
CCL.B CCL Industries	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$77.12 -2.1%	C$98.00 ➝ C$94.00
CCL.B CCL Industries	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$77.12 -2.1%	C$92.00 ➝ C$90.00
CCL.B CCL Industries	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$77.12 -2.1%	C$90.00 ➝ C$93.00
CCLD CareCloud	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.47 -3.5%	$4.50 ➝ $4.50	Buy ➝ Buy
CDW CDW	Initiated by	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		$177.63 -1.7%	$230.00	Buy
CDXS Codexis	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Kluska Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.88 +3.7%	$11.00 ➝ $11.00	Overweight ➝ Overweight
CELC Celcuity	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.66 -10.3%	$23.00 ➝ $23.00	Buy ➝ Buy
CELC Celcuity	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.66 -10.3%	$27.00 ➝ $27.00	Buy ➝ Buy
CFLT Confluent	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$27.07 -5.1%	$31.00 ➝ $31.00	Buy ➝ Buy
CGTX Cognition Therapeutics	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Gataulin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.46 -9.8%	$11.00 ➝ $11.00	Buy ➝ Buy
CIFR Cipher Mining	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.63 +3.3%	$6.00 ➝ $9.00	Buy ➝ Buy
CIX CI Financial	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$24.08 -1.8%	C$26.00 ➝ C$28.00	Buy
CIX CI Financial	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$24.08 -1.8%	C$25.00 ➝ C$26.00
CIX CI Financial	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Boland Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$24.08 -1.8%	C$22.00 ➝ C$27.00
CIX CI Financial	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Mackinnon Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$24.08 -1.8%	C$22.00 ➝ C$25.00
CLSD Clearside Biomedical	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Gataulin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.99 -5.7%	$6.00 ➝ $6.00	Buy ➝ Buy
CM Canadian Imperial Bank of Commerce	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$89.50 -0.4%	C$91.00 ➝ C$98.00
CMA Comerica	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$68.90 -1.7%	$51.00 ➝ $73.00	Underweight ➝ Equal Weight
CMG Chipotle Mexican Grill	Initiated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$58.62 -2.2%	$70.00 ➝ $70.00	Outperform ➝ Outperform
CMMB Chemomab Therapeutics	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.68 -3.5%	$13.00 ➝ $11.00	Outperform ➝ Outperform
CMPX Compass Therapeutics	Downgraded by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.38 -13.2%	$5.00 ➝ $4.00	Outperform ➝ Market Perform
CMTG Claros Mortgage Trust	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.70 -3.7%	$8.50 ➝ $8.00	Neutral ➝ Neutral
CNTA Centessa Pharmaceuticals	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.00 -8.6%	$24.00 ➝ $28.00	Buy ➝ Buy
CNVS Cineverse	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Kurnos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.20 +23.1%	$9.00 ➝ $10.00	Speculative Buy ➝ Speculative Buy
CORZ Core Scientific	Initiated by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.83 +2.5%	$25.50	Buy
CORZ Core Scientific	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Lewis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.83 +2.5%	$15.00 ➝ $19.00	Buy ➝ Buy
CPRI Capri	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.00 +2.3%	$26.00 ➝ $23.00	Market Perform ➝ Market Perform
CPRI Capri	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.00 +2.3%	$57.00 ➝ $22.00	Hold ➝ Hold
CRBU Caribou Biosciences	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.99 -4.8%	$9.00 ➝ $9.00	Buy ➝ Buy
CRGX CARGO Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Burns Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.00 -5.9%	$33.00 ➝ $33.00	Buy ➝ Buy
CRIS Curis	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.95 -0.8%	$20.00 ➝ $20.00	Buy ➝ Buy
CRM Salesforce	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$325.28 -1.9%	$305.00 ➝ $385.00	Outperform ➝ Outperform
CTRA Coterra Energy	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.55 +0.5%	$31.00 ➝ $35.00	Buy ➝ Buy
CTRA Coterra Energy	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.55 +0.5%	$32.00 ➝ $35.00	Overweight ➝ Overweight
CU Canadian Utilities	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$34.98 +1.7%	C$38.00 ➝ C$39.00
CVS CVS Health	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$53.19 -3.4%	$68.00 ➝ $58.00	Outperform ➝ Outperform
Top "Sleeping Giant" Crypto In The Market Now (Ad) Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future. Click here to discover our #1 crypto pick before it's too late
DADA Dada Nexus	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Yap Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.38 +0.7%	$2.00 ➝ $1.90	Neutral ➝ Neutral
DAL Delta Air Lines	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$64.07 -1.2%	$83.00	Buy
DARE Daré Bioscience	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.21 -10.1%	$12.00 ➝ $12.00	Buy ➝ Buy
DDD 3D Systems	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Ricchiuti Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.97 +4.2%		Hold
DDS Dillard's	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$427.48 -1.3%	$380.00 ➝ $450.00	Market Perform ➝ Market Perform
DDS Dillard's	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$427.48 -1.3%	$194.00 ➝ $198.00	Sell ➝ Sell
DFLI Dragonfly Energy	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.49 -7.5%	$1.50 ➝ $1.25	Buy ➝ Buy
DG Dollar General	Target Lowered by	Bernstein Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$75.88 -1.5%	$98.00 ➝ $94.00
DG Dollar General	Target Lowered by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$75.88 -1.5%	$100.00 ➝ $88.00	Hold ➝ Hold
DG Dollar General	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$75.88 -1.5%	$101.00 ➝ $97.00	Hold ➝ Hold
DG Dollar General	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$75.88 -1.5%	$110.00 ➝ $90.00	Buy ➝ Buy
DII.B Dorel Industries	Downgraded by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$4.15 -5.9%	C$12.00 ➝ C$4.50	Buy ➝ Hold
DII.B Dorel Industries	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$4.15 -5.9%	C$7.00 ➝ C$5.00
DIN Dine Brands Global	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Setyan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$35.30 -0.8%	$47.00 ➝ $47.00	Outperform ➝ Outperform
DIS Walt Disney	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$115.06 +5.4%	$115.00 ➝ $131.00	Buy ➝ Buy
DIS Walt Disney	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$115.06 +5.4%	$110.00 ➝ $125.00	Overweight ➝ Overweight
DIS Walt Disney	Target Raised by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating		$115.06 +5.4%	$91.00 ➝ $110.00	Neutral ➝ Neutral
DIS Walt Disney	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$115.06 +5.4%	$120.00 ➝ $140.00	Buy ➝ Buy
DIS Walt Disney	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$115.06 +5.4%	$116.00 ➝ $138.00	Overweight ➝ Overweight
DIS Walt Disney	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		$115.06 +5.4%	$115.00 ➝ $120.00	Outperform ➝ Outperform
DIS Walt Disney	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$115.06 +5.4%	$110.00 ➝ $130.00	Buy ➝ Buy
DIS Walt Disney	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$115.06 +5.4%	$108.00 ➝ $123.00	Hold ➝ Hold
DIS Walt Disney	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$115.06 +5.4%	$110.00 ➝ $130.00	Buy ➝ Buy
DIS Walt Disney	Target Raised by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$115.06 +5.4%	$120.00 ➝ $125.00	Buy ➝ Buy
DLPN Dolphin Entertainment	Target Lowered by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.10 -6.0%	$8.00 ➝ $5.00	Buy ➝ Buy
DMAC DiaMedica Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.01 -2.7%	$7.00 ➝ $7.00	Buy ➝ Buy
DMRC Digimarc	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Reilly Subscribe to MarketBeat All Access for the recommendation accuracy rating	$27.17 -9.8%	$40.00 ➝ $40.00	Buy ➝ Buy
DOCS Doximity	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$49.42 -5.0%	$58.00	Neutral
DRH DiamondRock Hospitality	Downgraded by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.85 -2.1%	$10.50 ➝ $10.50	Outperform ➝ Inline
DSGX The Descartes Systems Group	Upgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$111.41 -0.5%	$88.00 ➝ $125.00	Underweight ➝ Equal Weight
DTI Drilling Tools International	Target Lowered by	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Grampp Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.49 +0.3%	$7.50 ➝ $5.50	Buy ➝ Buy
DY Dycom Industries	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$187.59 +1.6%	$200.00 ➝ $215.00	Overweight ➝ Overweight
ECG Everus	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.34 -0.7%	$71.00	Buy
EFN Element Fleet Management	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$27.11 +0.1%	C$32.00 ➝ C$30.00	Buy ➝ Hold
EFX Enerflex	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$11.75 +4.3%	C$12.00 ➝ C$15.00	Buy
EFX Enerflex	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$11.75 +4.3%	C$12.00 ➝ C$13.75
EFX Enerflex	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$11.75 +4.3%	C$11.00 ➝ C$15.00
EFX Enerflex	Target Raised by	ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$11.75 +4.3%	C$12.00 ➝ C$15.00
EFX Enerflex	Target Raised by	Acumen Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$11.75 +4.3%	C$12.00 ➝ C$15.00
EFXT Enerflex	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.34 +4.4%	$9.00 ➝ $12.00	Outperform ➝ Outperform
ELUT Elutia	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.56 -7.0%	$10.00 ➝ $10.00	Overweight ➝ Overweight
ELVN Enliven Therapeutics	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.41 -2.0%	$32.00 ➝ $40.00	Outperform ➝ Outperform
EME EMCOR Group	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$498.74 +0.1%	$600.00	Buy
ENLT Enlight Renewable Energy	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.21 -1.0%	$20.00 ➝ $21.00	Overweight ➝ Overweight
ENPH Enphase Energy	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.52 -6.4%	$93.00 ➝ $74.00	Equal Weight ➝ Equal Weight
ESE ESCO Technologies	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Sullivan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$144.16 +3.0%	$150.00 ➝ $150.00	Buy ➝ Buy
ESRT Empire State Realty Trust	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.60 +0.6%	$12.00 ➝ $13.00	Outperform ➝ Outperform
ESTC Elastic	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Lenschow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$86.36 -3.2%	$95.00 ➝ $105.00	Overweight ➝ Overweight
EWCZ European Wax Center	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.90 -4.2%	$5.00 ➝ $5.00	Equal Weight ➝ Underweight
FA First Advantage	Initiated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.50 -2.0%	$22.00 ➝ $22.00	Outperform ➝ Outperform
This company will win the AI race (Ad) Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry.
FDS FactSet Research Systems	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$483.90 -2.4%	$503.00 ➝ $503.00	Sector Perform ➝ Sector Perform
FDS FactSet Research Systems	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$483.90 -2.4%	$485.00 ➝ $525.00	Neutral ➝ Neutral
FDS FactSet Research Systems	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$483.90 -2.4%	$471.00 ➝ $521.00	Market Perform ➝ Market Perform
FITB Fifth Third Bancorp	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.99 -0.6%	$52.00 ➝ $54.00	Overweight ➝ Overweight
FIX Comfort Systems USA	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$445.02 +1.3%	$524.00	Buy
FPAY FlexShopper	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.53 +4.8%	$2.50 ➝ $2.50	Buy ➝ Buy
FPAY FlexShopper	Target Raised by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.53 +4.8%	$2.00 ➝ $4.00	Buy ➝ Buy
GALT Galectin Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.77 +0.7%	$11.00 ➝ $11.00	Buy ➝ Buy
GAMB Gambling.com Group	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.77 -5.3%	$13.00 ➝ $16.00	Buy ➝ Buy
GAMB Gambling.com Group	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.77 -5.3%	$13.00 ➝ $14.00	Buy ➝ Buy
GAMB Gambling.com Group	Target Raised by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.77 -5.3%	$14.00 ➝ $16.00	Buy ➝ Buy
GEV GE Vernova	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$329.76 +1.1%	$301.00 ➝ $367.00	Overweight ➝ Overweight
GGR Gogoro	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.48	$2.30 ➝ $0.50	Buy ➝ Neutral
GILD Gilead Sciences	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$88.40 -4.0%	$110.00	Outperform
GILT Gilat Satellite Networks	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.03 +3.3%	$8.50 ➝ $8.50	Buy ➝ Buy
GIS General Mills	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.21 -2.3%	$77.00 ➝ $70.00	Equal Weight ➝ Equal Weight
GLOB Globant	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$203.16 -11.2%	$240.00 ➝ $237.00	Overweight ➝ Overweight
GLOB Globant	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$203.16 -11.2%	$230.00 ➝ $240.00	Buy ➝ Buy
GLOB Globant	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$203.16 -11.2%	$245.00 ➝ $265.00	Buy ➝ Buy
GNLX Genelux	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.36 -19.7%	$32.00 ➝ $30.00	Buy ➝ Buy
GOEV Canoo	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.50 -5.6%	$4.00 ➝ $2.00	Buy ➝ Buy
GOVX GeoVax Labs	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.43 -6.9%	$8.00 ➝ $8.00	Buy ➝ Buy
GPMT Granite Point Mortgage Trust	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.27 -2.4%	$3.50 ➝ $4.00	Buy ➝ Buy
GRAL Grail	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.80 -6.4%		Peer Perform
GRDN Guardian Pharmacy Services	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Macdonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.93 -0.3%	$22.00 ➝ $24.00	Buy ➝ Buy
GS The Goldman Sachs Group	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$593.51 +0.8%	$600.00 ➝ $680.00	Overweight ➝ Overweight
GSK GSK	Downgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.35 -1.9%		Buy ➝ Hold
HAE Haemonetics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Matson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$89.24 -1.7%	$112.00 ➝ $112.00	Buy ➝ Buy
HAFC Hanmi Financial	Upgraded by	Janney Montgomery Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.65 +1.2%		Neutral ➝ Buy
HI Hillenbrand	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Summerville Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.75 -2.8%	$33.00 ➝ $33.00	Neutral ➝ Neutral
HOOK Hookipa Pharma	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.00 -4.5%	$50.00 ➝ $48.00	Outperform ➝ Outperform
HP Helmerich & Payne	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.85 -0.3%	$44.00 ➝ $41.00	Sector Perform ➝ Sector Perform
HPP Hudson Pacific Properties	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Goldfarb Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.68 -7.3%	$5.00 ➝ $4.50	Neutral ➝ Neutral
HQI HireQuest	Target Raised by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.30 -0.4%	$17.00 ➝ $18.00	Outperform ➝ Outperform
HQY HealthEquity	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$98.98 +3.4%	$108.00	Neutral
HR.UN H&R Real Estate Investment Trust	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$10.00 -0.2%	C$11.50 ➝ C$11.75
HST Host Hotels & Resorts	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.26 -1.1%	$20.00 ➝ $19.00	Neutral ➝ Neutral
IHG InterContinental Hotels Group	Upgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$121.26 +0.2%		Equal Weight ➝ Overweight
IMAB I-Mab	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.04 -2.8%	$8.00 ➝ $8.00	Buy ➝ Buy
IMMP Immutep	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.05 -1.9%	$6.00 ➝ $7.00	Outperform ➝ Outperform
INGR Ingredion	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$140.79 -5.6%	$165.00 ➝ $173.00	Buy ➝ Buy
INKT MiNK Therapeutics	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.75	$8.00 ➝ $4.00	Outperform ➝ Outperform
INKT MiNK Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.75	$9.00 ➝ $9.00	Buy ➝ Buy
INO Inovio Pharmaceuticals	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.27 -10.5%	$7.00 ➝ $6.00	Sector Perform ➝ Sector Perform
INSG Inseego	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.88 -3.5%	$20.00 ➝ $16.00	Hold ➝ Hold
INTU Intuit	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$687.87 -1.8%	$740.00 ➝ $800.00	Overweight ➝ Overweight
IPO InPlay Oil	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$1.73 -3.4%	C$3.25 ➝ C$3.00
IRT Independence Realty Trust	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.97 +0.6%	$19.00 ➝ $21.00	Underperform ➝ Market Perform
ITOS iTeos Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.23 -2.7%	$46.00 ➝ $46.00	Buy ➝ Buy
JACK Jack in the Box	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.76 -3.6%	$70.00 ➝ $60.00	Outperform ➝ Outperform
JBLU JetBlue Airways	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.06 -0.7%	$5.50	Sell
JD JD.com	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.00 +4.9%	$47.00 ➝ $47.00	Buy ➝ Buy
JD JD.com	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.00 +4.9%	$52.00 ➝ $51.00	Buy ➝ Buy
JJSF J&J Snack Foods	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$161.77 -2.8%	$200.00 ➝ $200.00	Buy ➝ Buy
JNJ Johnson & Johnson	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$153.99 +1.4%	$190.00	Outperform
JPM JPMorgan Chase & Co.	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$245.39 +1.5%	$240.00 ➝ $270.00	Overweight ➝ Overweight
KALA KALA BIO	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.70 -0.9%	$15.00 ➝ $15.00	Buy ➝ Buy
KBL K-Bro Linen	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$34.82 +0.1%	C$46.00 ➝ C$48.00
KBL K-Bro Linen	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$34.82 +0.1%	C$45.00 ➝ C$46.00
KEY Keyera	Target Raised by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$45.11 +1.4%	C$38.00 ➝ C$39.00
KEY Keyera	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Pham Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$45.11 +1.4%	C$41.00 ➝ C$44.00
KEY Keyera	Target Raised by	ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$45.11 +1.4%	C$43.00 ➝ C$44.00
KEY KeyCorp	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.16 +0.1%	$20.00 ➝ $22.00	Overweight ➝ Overweight
KLIC Kulicke and Soffa Industries	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.19 +1.3%	$65.00 ➝ $60.00	Buy ➝ Buy
KLIC Kulicke and Soffa Industries	Upgraded by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.19 +1.3%	$55.00	Hold ➝ Buy
KLIC Kulicke and Soffa Industries	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.19 +1.3%	$45.00 ➝ $50.00	Hold ➝ Hold
KMI Kinder Morgan	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Reynolds Subscribe to MarketBeat All Access for the recommendation accuracy rating	$27.27 +1.9%	$30.00 ➝ $33.00	Buy ➝ Buy
KOD Kodiak Sciences	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.53 +4.3%	$3.00 ➝ $3.00	Neutral ➝ Neutral
KOD Kodiak Sciences	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.53 +4.3%	$3.00 ➝ $4.00	Underweight ➝ Underweight
KRG Kite Realty Group Trust	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.69 -0.6%	$26.00 ➝ $29.00	Neutral ➝ Neutral
KYTX Kyverna Therapeutics	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.35 -9.4%	$44.00 ➝ $24.00	Overweight ➝ Overweight
LBRDA Liberty Broadband	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$87.64 -1.8%	$90.00 ➝ $95.00	Buy ➝ Hold
LCFS Tidewater Renewables	Target Lowered by	ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$1.02 -11.3%	C$5.00 ➝ C$3.00	Outperform ➝ Speculative Buy
LLY Eli Lilly and Company	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$745.89 -5.0%	$1,000.00	Outperform
LMB Limbach	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$92.09 +3.7%	$108.00	Buy
LMND Lemonade	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.30 +5.0%	$15.00 ➝ $23.00	Underweight ➝ Underweight
LNG Cheniere Energy	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$212.30 +0.7%	$232.00 ➝ $265.00	Buy ➝ Buy
LPTX Leap Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.74 -5.2%	$5.50 ➝ $5.50	Buy ➝ Buy
LSTR Landstar System	Downgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$182.82 -2.4%		Outperform ➝ Market Perform
LUC Lucara Diamond	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$0.45 +7.1%	C$0.60 ➝ C$0.50
LUCD Lucid Diagnostics	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.99 -2.0%	$3.00 ➝ $2.00	Overweight ➝ Overweight
LUNR Intuitive Machines	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.42 +21.4%	$10.00 ➝ $16.00	Buy ➝ Buy
LUNR Intuitive Machines	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.42 +21.4%	$10.00 ➝ $15.00	Overweight ➝ Overweight
LUNR Intuitive Machines	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.42 +21.4%	$11.00 ➝ $12.50	Buy ➝ Buy
LUV Southwest Airlines	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.61 +0.6%	$28.00	Sell
LYV Live Nation Entertainment	Target Raised by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating		$129.00 -0.1%	$130.00 ➝ $146.00	Outperform ➝ Outperform
MA Mastercard	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$521.89 +0.3%	$533.00 ➝ $567.00	Buy ➝ Buy
MA Mastercard	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$521.89 +0.3%	$565.00 ➝ $575.00	Overweight ➝ Overweight
MDB MongoDB	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$279.77 -4.1%	$290.00 ➝ $345.00	Overweight ➝ Overweight
MDT Medtronic	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$87.53 +1.8%	$99.00 ➝ $96.00	Neutral ➝ Neutral
MDT Medtronic	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$87.53 +1.8%	$90.00 ➝ $96.00
MLR Miller Industries	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Shlisky Subscribe to MarketBeat All Access for the recommendation accuracy rating	$66.16 -1.9%	$82.00 ➝ $82.00	Buy ➝ Buy
MPLX Mplx	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$47.06 +1.4%	$51.00 ➝ $55.00	Buy ➝ Buy
MRK Merck & Co., Inc.	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$96.30 -2.1%		Peer Perform
MRNA Moderna	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$36.85 -7.3%	$40.00	Underperform
MRSN Mersana Therapeutics	Initiated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.21 -12.3%	$5.00	Buy
MS Morgan Stanley	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$134.06 +1.2%	$107.00 ➝ $142.00	Underweight ➝ Equal Weight
MTB M&T Bank	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$214.74 +0.7%	$190.00 ➝ $205.00	Underweight ➝ Underweight
NA National Bank of Canada	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$133.67 +0.3%	C$129.00 ➝ C$140.00
NEXN Nexxen International	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.48 -2.5%	$8.50 ➝ $9.50	Buy ➝ Buy
NICE NICE	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$172.62 -5.3%	$230.00 ➝ $215.00	Buy ➝ Buy
NICE NICE	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$172.62 -5.3%	$260.00 ➝ $260.00	Outperform ➝ Outperform
NICE NICE	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$172.62 -5.3%	$300.00 ➝ $225.00	Buy ➝ Buy
NICE NICE	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$172.62 -5.3%		Outperform ➝ Market Perform
NICE NICE	Target Lowered by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$172.62 -5.3%	$275.00 ➝ $250.00	Outperform ➝ Outperform
NOVA Sunnova Energy International	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.74 -7.2%	$12.00 ➝ $6.00	Equal Weight ➝ Equal Weight
NSIT Insight Enterprises	Initiated by	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		$151.50 -0.7%	$220.00	Buy
NTES NetEase	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$85.49 +1.5%	$120.00 ➝ $105.00	Buy ➝ Buy
NTES NetEase	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$85.49 +1.5%	$108.00 ➝ $115.00	Buy ➝ Buy
NTRS Northern Trust	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$107.60 +1.5%	$108.00 ➝ $110.00	Equal Weight ➝ Equal Weight
OBIO Orchestra BioMed	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Y. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.84 -6.0%	$14.00 ➝ $14.00	Buy ➝ Buy
OCUL Ocular Therapeutix	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.16 -7.7%	$14.00 ➝ $15.00	Buy ➝ Buy
OKE ONEOK	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$109.81 +1.8%	$112.00 ➝ $132.00	Buy ➝ Buy
OMAB Grupo Aeroportuario del Centro Norte	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.09 -4.2%	$71.50	Buy ➝ Underperform
OMGA Omega Therapeutics	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.83 -18.0%	$9.00 ➝ $4.00	Overweight ➝ Overweight
OMGA Omega Therapeutics	Downgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Deschner Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.83 -18.0%		Outperform ➝ Market Perform
ONEW OneWater Marine	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.00 -5.8%	$29.00 ➝ $27.00	Overweight ➝ Overweight
ONEW OneWater Marine	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Albanese Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.00 -5.8%		Hold
ONEW OneWater Marine	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.00 -5.8%	$34.00 ➝ $31.00	Buy ➝ Buy
ORCL Oracle	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$183.71 -1.8%	$190.00 ➝ $200.00	Overweight ➝ Overweight
OVV Ovintiv	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$43.80 -2.1%	$57.00 ➝ $59.00	Buy ➝ Buy
OVV Ovintiv	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$43.80 -2.1%	$53.00 ➝ $57.00	Overweight ➝ Overweight
OWL Blue Owl Capital	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.59 -0.5%	$25.00 ➝ $27.00	Market Outperform ➝ Market Outperform
PAA Plains All American Pipeline	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.18 +0.2%	$19.00 ➝ $19.00	Sector Perform ➝ Sector Perform
PAGS PagSeguro Digital	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Labarta Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.65 -2.2%	$14.00 ➝ $12.00	Buy ➝ Buy
PANW Palo Alto Networks	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$387.00 -1.9%	$385.00 ➝ $425.00	Outperform ➝ Outperform
PAY Paymentus	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.49 +2.9%	$23.50 ➝ $33.00	Neutral ➝ Neutral
PBL Pollard Banknote	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$25.90 -0.8%	C$44.00 ➝ C$46.00
PDSB PDS Biotechnology	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.01 -10.7%	$21.00 ➝ $21.00	Buy ➝ Buy
PFE Pfizer	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.80 -4.7%	$25.00	Underperform
PFS Provident Financial Services	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.40 +1.0%	$24.00 ➝ $27.00	Buy ➝ Buy
PGEN Precigen	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.82 -6.8%	$4.00 ➝ $4.00	Buy ➝ Buy
PNC The PNC Financial Services Group	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$207.68 -0.1%	$215.00 ➝ $235.00	Overweight ➝ Overweight
POU Paramount Resources	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$31.01 -1.0%	C$43.00 ➝ C$44.00
POU Paramount Resources	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$31.01 -1.0%	C$34.00 ➝ C$37.00
POU Paramount Resources	Target Raised by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$31.01 -1.0%	C$38.00 ➝ C$39.50
PPTA Perpetua Resources	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.60 +16.5%	$13.25 ➝ $22.00	Buy ➝ Buy
PRV.UN PRO Real Estate Investment Trust	Target Raised by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$2.30 +0.4%	C$6.25 ➝ C$6.50
PSTX Poseida Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.76 -14.0%	$20.00 ➝ $20.00	Buy ➝ Buy
QBTS D-Wave Quantum	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.64 -12.8%	$2.25 ➝ $2.25	Buy ➝ Buy
RC Ready Capital	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.02 -0.7%	$8.50 ➝ $7.50	Neutral ➝ Neutral
RDZN Roadzen	Target Lowered by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Klee Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.80 -1.2%	$7.00 ➝ $4.00	Buy ➝ Buy
REGN Regeneron Pharmaceuticals	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$756.81 -3.3%	$1,150.00	Outperform
REKR Rekor Systems	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.90 -17.5%		Outperform
RF Regions Financial	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.36 +0.3%	$24.00 ➝ $28.00	Equal Weight ➝ Equal Weight
RGNX REGENXBIO	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.63 -13.6%	$22.00	Overweight
ROK Rockwell Automation	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$286.15 -0.1%	$320.00 ➝ $335.00	Overweight ➝ Overweight
RUN Sunrun	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.89 -9.3%	$35.00 ➝ $27.00	Overweight ➝ Overweight
RY Royal Bank of Canada	Downgraded by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$121.48 -0.7%		Buy ➝ Hold
RY Royal Bank of Canada	Downgraded by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$171.13 -0.5%	C$178.00 ➝ C$180.00	Buy ➝ Hold
SACH Sachem Capital	Downgraded by	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.79 -1.7%	$2.00	Buy ➝ Neutral
SBH Sally Beauty	Upgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.41 -2.7%		Underperform ➝ Market Perform
SBH Sally Beauty	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.41 -2.7%	$8.00 ➝ $12.00	Underweight ➝ Underweight
SBH Sally Beauty	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.41 -2.7%	$12.00 ➝ $13.00	Neutral ➝ Neutral
SBH Sally Beauty	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.41 -2.7%	$13.00 ➝ $14.00	Hold ➝ Hold
SBUX Starbucks	Initiated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$98.42 -0.2%	$115.00 ➝ $115.00	Outperform ➝ Outperform
SCR Strathcona Resources	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$32.21 -0.9%	C$30.00 ➝ C$31.00
SCR Strathcona Resources	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Bouvier Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$32.21 -0.9%	C$35.00 ➝ C$37.00
SCR Strathcona Resources	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$32.21 -0.9%	C$34.00 ➝ C$36.00
SCR Strathcona Resources	Target Raised by	ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$32.21 -0.9%	C$37.00 ➝ C$38.00
SEDG SolarEdge Technologies	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.64 -17.1%	$23.00 ➝ $9.00	Equal Weight ➝ Underweight
SEDG SolarEdge Technologies	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.64 -17.1%	$17.00 ➝ $7.00	Underweight ➝ Underperform
SENS Senseonics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.28	$2.00 ➝ $2.00	Buy ➝ Buy
SGMT Sagimet Biosciences	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.73 -8.7%	$32.00 ➝ $32.00	Buy ➝ Buy
SHLS Shoals Technologies Group	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.56 -12.6%	$8.00 ➝ $7.00	Equal Weight ➝ Equal Weight
SKT Tanger	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.86 +0.4%	$31.00 ➝ $35.00	Neutral ➝ Neutral
SKYW SkyWest	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$111.33 +0.5%	$119.00	Neutral
SLN Silence Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.70 -9.2%	$75.00 ➝ $75.00	Buy ➝ Buy
SLP Simulations Plus	Initiated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.77 -3.2%	$39.00	Overweight
SNCY Sun Country Airlines	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.89 -3.5%	$17.00	Neutral
SOC Sable Offshore	Reiterated by	BWS Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	H. Khorsand Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.62 -8.3%	$6.00 ➝ $6.00	Sell ➝ Sell
SOL Emeren Group	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.91 -4.5%	$7.00 ➝ $7.00	Buy ➝ Buy
SOWG Sow Good	Downgraded by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.76 -11.3%	$17.00 ➝ $4.00	Buy ➝ Neutral
SOWG Sow Good	Downgraded by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.76 -11.3%	$4.50	Buy ➝ Hold
SPIR Spire Global	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.48 +1.0%	$12.00 ➝ $18.00	Buy ➝ Buy
SPRO Spero Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.18 -5.6%		Overweight
SQ Block	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Jeffrey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$84.30 +1.1%		Outperform
SRTS Sensus Healthcare	Target Raised by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.64 +4.8%	$12.00 ➝ $14.00	Buy ➝ Buy
SRU.UN SmartCentres Real Estate Investment Trst	Target Raised by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$25.11 +0.6%	C$28.00 ➝ C$29.00
STT State Street	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$95.48 +1.4%	$106.00 ➝ $108.00	Overweight ➝ Overweight
STTK Shattuck Labs	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Pantginis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.24 -10.2%		Neutral
STWD Starwood Property Trust	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.47 -0.5%	$19.50 ➝ $20.00	Neutral ➝ Neutral
SW Smurfit Westrock	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Mckellar Subscribe to MarketBeat All Access for the recommendation accuracy rating	$51.66 +3.2%	$58.00 ➝ $58.00	Outperform ➝ Outperform
SYBT Stock Yards Bancorp	Downgraded by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.25 -1.6%	$70.00 ➝ $76.00	Overweight ➝ Equal Weight
TARS Tarsus Pharmaceuticals	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.83 -3.9%	$36.00 ➝ $41.00	Neutral ➝ Neutral
TCRX TScan Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.41 -8.5%	$15.00 ➝ $15.00	Buy ➝ Buy
TDOC Teladoc Health	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.20 +2.6%	$14.00	Buy
TFC Truist Financial	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.54 +0.6%	$48.00 ➝ $52.00	Overweight ➝ Overweight
THS TreeHouse Foods	Downgraded by	Consumer Edge Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.40 -2.6%		Overweight ➝ Equal Weight
TJX TJX Companies	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$119.98 +0.1%	$125.00 ➝ $130.00	Buy ➝ Buy
TLN Talen Energy	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$200.43 -1.4%	$197.00 ➝ $242.00	Buy ➝ Buy
TLSI TriSalus Life Sciences	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.93 -2.0%	$12.00 ➝ $11.00	Buy ➝ Buy
TMQ Trilogy Metals	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Hutchison Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$1.76 +34.4%	C$0.75 ➝ C$1.50	Hold
TPIC TPI Composites	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.17 -8.8%	$4.00 ➝ $2.00	Equal Weight ➝ Underweight
TPR Tapestry	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$57.23 -1.0%	$60.00 ➝ $70.00	Buy ➝ Buy
TPR Tapestry	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$57.23 -1.0%	$65.00 ➝ $75.00	Overweight ➝ Overweight
TPR Tapestry	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$57.23 -1.0%	$58.00 ➝ $67.00	Outperform ➝ Outperform
TPR Tapestry	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$57.23 -1.0%	$58.00 ➝ $64.00	Outperform ➝ Outperform
TPR Tapestry	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$57.23 -1.0%	$58.00 ➝ $66.00	Buy ➝ Buy
TRGP Targa Resources	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$196.04 +2.3%	$182.00 ➝ $246.00	Buy ➝ Buy
TRGP Targa Resources	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$196.04 +2.3%	$175.00 ➝ $225.00	Buy ➝ Buy
TSBX Turnstone Biologics	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.49 -7.5%		Neutral ➝ Underperform
TSHA Taysha Gene Therapies	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.06 -9.3%	$6.00 ➝ $8.00	Buy ➝ Buy
TSLA Tesla	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$320.72 +3.1%	$249.00 ➝ $313.00	Outperform ➝ Outperform
TTEK Tetra Tech	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.27 +0.8%	$52.00 ➝ $52.00	Outperform ➝ Outperform
TTEK Tetra Tech	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.27 +0.8%	$56.00 ➝ $49.00	Overweight ➝ Overweight
TV Grupo Televisa, S.A.B.	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.12 -3.6%	$2.90 ➝ $2.50	Buy ➝ Buy
TWLO Twilio	Upgraded by	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the recommendation accuracy rating		$96.54 -0.6%	$135.00	Neutral ➝ Buy
TWM Tidewater Midstream and Infrastructure	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$0.13 +8.3%	C$0.40 ➝ C$0.30
TWM Tidewater Midstream and Infrastructure	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Hope Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$0.13 +8.3%	C$0.45 ➝ C$0.30
UAL United Airlines	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$91.17 +0.0%	$119.00	Buy
UGI UGI	Upgraded by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.12 +3.8%	$27.00 ➝ $30.00	Neutral ➝ Outperform
ULBI Ultralife	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.36 -4.0%	$14.00 ➝ $14.00	Buy ➝ Buy
USB U.S. Bancorp	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$49.90 -0.8%	$60.00 ➝ $62.00	Overweight ➝ Overweight
UTI Universal Technical Institute	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.61 +0.4%	$22.00 ➝ $22.00	Outperform ➝ Outperform
VCM Vecima Networks	Target Lowered by	Accountability Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$17.50 -0.1%	C$27.00 ➝ C$24.00
VCYT Veracyte	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.94 -3.0%	$50.00	Outperform
WES Western Midstream Partners	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.20 +1.1%	$40.00 ➝ $37.00	Neutral ➝ Neutral
WMB Williams Companies	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.55 +1.7%	$55.00 ➝ $70.00	Buy ➝ Buy
WMT Walmart	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$84.27 -0.2%	$90.00 ➝ $100.00	Buy ➝ Buy
WPRT Westport Fuel Systems	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.15 +2.5%	$22.00 ➝ $22.00	Buy ➝ Buy
WSM Williams-Sonoma	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$130.66 -0.1%	$165.00 ➝ $165.00	Outperform ➝ Outperform
YMAB Y-mAbs Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.14 -3.9%	$22.00 ➝ $22.00	Buy ➝ Buy
ZETA Zeta Global	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.59 +1.3%	$41.00 ➝ $26.00	Equal Weight ➝ Equal Weight
ZION Zions Bancorporation, National Association	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.51 -0.2%	$54.00 ➝ $62.00	Equal Weight ➝ Equal Weight
ZNTL Zentalis Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.47 -12.2%	$20.00 ➝ $20.00	Buy ➝ Buy
ZNTL Zentalis Pharmaceuticals	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.47 -12.2%	$12.00 ➝ $8.00	Buy ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 08:49 PM ET.

(Ad)

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

analyst ratings Headlines

How Whitestone REIT is Transforming Sunbelt Retail Growth
By Jeffrey Neal Johnson | November 15, 2024
View How Whitestone REIT is Transforming Sunbelt Retail Growth
How major US stock indexes fared Friday, 11/15/2024
By The Associated Press | November 15, 2024
View How major US stock indexes fared Friday, 11/15/2024
Company announces nearly $712 million project in Kentucky to make batteries used to store energy
By The Associated Press | November 15, 2024
View Company announces nearly $712 million project in Kentucky to make batteries used to store energy
Creator Economy Survival Guide — How to Turn Short-Form Content into Long-Term Success
By Entrepreneur | November 15, 2024
View Creator Economy Survival Guide — How to Turn Short-Form Content into Long-Term Success
Want Your Workers to Be More Productive? You Need a Better Way to Measure Their Contributions
By Entrepreneur | November 15, 2024
View Want Your Workers to Be More Productive? You Need a Better Way to Measure Their Contributions
Amazon: Why Analysts Think It's a Solid Buy Ahead of Earnings
By Sam Quirke | October 28, 2024
View Amazon: Why Analysts Think It's a Solid Buy Ahead of Earnings
J.B. Hunt Stock on the Move: Analysts Forecast Big Gains Ahead
By Thomas Hughes | October 17, 2024
View J.B. Hunt Stock on the Move: Analysts Forecast Big Gains Ahead

Top Headlines and Offers

View All

SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
By Thomas Hughes | November 13, 2024
View SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
3 "Made in America" Stocks to Benefit From the Trump Presidency
By Jea Yu | November 11, 2024
View 3 "Made in America" Stocks to Benefit From the Trump Presidency
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
From Crypto Swap Profits(Ad)
View [625,000% Gain] – Are You Ready for the Next Altcoin Boom?
2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
By Jea Yu | November 11, 2024
View 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
Is Tesla's Valuation a Bubble or Backed by Real Growth?
By Gabriel Osorio-Mazilli | November 12, 2024
View Is Tesla's Valuation a Bubble or Backed by Real Growth?
California Resources Stock Could Be a Huge Long-Term Winner
By Leo Miller | November 10, 2024
View California Resources Stock Could Be a Huge Long-Term Winner
Watch this before it gets removed
From Porter & Company(Ad)
View Watch this before it gets removed
The S&P 500 Can Gain 20% and Hit 7,400: Here’s How
By Thomas Hughes | November 12, 2024
View The S&P 500 Can Gain 20% and Hit 7,400: Here’s How
Monday.com’s Manic Price Pullback Is a Signal to Buy
By Thomas Hughes | November 11, 2024
View Monday.com’s Manic Price Pullback Is a Signal to Buy
Rocket Lab is the Right Stock for the Right Time
By Chris Markoch | November 13, 2024
View Rocket Lab is the Right Stock for the Right Time
Archer Aviation: Taking Off in Tokyo and Beyond?
By Jeffrey Neal Johnson | November 11, 2024
View Archer Aviation: Taking Off in Tokyo and Beyond?
Trump’s Return: Which Sectors Will Benefit Most?
By Jeffrey Neal Johnson | November 9, 2024
View Trump’s Return: Which Sectors Will Benefit Most?

Stock Forecasts and Research Tools

Today's Ratings

Top Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings